Title : Modulating TAK1 Expression Inhibits YAP and TAZ Oncogenic Functions in Pancreatic Cancer.

Pub. Date : 2020 Jan

PMID : 31562256






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In vivo, LY2090314 plus nab-paclitaxel significantly prolonged mice survival duration.Our study demonstrates a unique role for TAK1 in controlling YAP/TAZ in pancreatic cancer. 3-(9-fluoro-2-(piperidin-1-ylcarbonyl)-1,2,3,4-tetrahydro(1,4)diazepino(6,7,1-hi)indol-7-yl)-4-imidazo(1,2-a)pyridin-3-yl-1H-pyrrole-2,5-dione tafazzin, phospholipid-lysophospholipid transacylase Mus musculus
2 In vivo, LY2090314 plus nab-paclitaxel significantly prolonged mice survival duration.Our study demonstrates a unique role for TAK1 in controlling YAP/TAZ in pancreatic cancer. nab tafazzin, phospholipid-lysophospholipid transacylase Mus musculus
3 In vivo, LY2090314 plus nab-paclitaxel significantly prolonged mice survival duration.Our study demonstrates a unique role for TAK1 in controlling YAP/TAZ in pancreatic cancer. Paclitaxel tafazzin, phospholipid-lysophospholipid transacylase Mus musculus